IDEXX LABORATORIES INC /DE·4

May 11, 5:10 PM ET

SZOSTAK M ANNE 4

4 · IDEXX LABORATORIES INC /DE · Filed May 11, 2026

Research Summary

AI-generated summary of this filing

Updated

IDEXX Director M. Anne Szostak Receives 257 Shares (RSU Vest)

What Happened
M. Anne Szostak, a director of IDEXX Laboratories (IDXX), had 257 restricted stock units (RSUs) vest and convert into 257 shares on May 7, 2026. The filing shows the shares were acquired at $0.00 (no cash paid) as a conversion/vesting event (transaction code M). There is no indication these shares were sold immediately.

Key Details

  • Transaction date: May 7, 2026 (reported on Form 4 filed May 11, 2026). Filing appears timely (filed by the SEC deadline).
  • Shares acquired: 257 shares via RSU conversion; reported acquisition price: $0.00 (no cash outlay).
  • Shares disposed: the filing shows the derivative conversion entry but no market sale of the resulting shares.
  • Shares owned after transaction: not specified in the portion of the filing provided.
  • Notable footnotes:
    • F3 confirms each RSU converted to one share and vested in one installment on May 7, 2026.
    • F1–F2 note Szostak’s roles with a trust and a family foundation and that she has a pecuniary interest in shares held by those entities.

Context
This was a routine vesting/conversion of director RSUs (an award being settled in shares), not an open-market purchase or sale. Such vesting events typically create ordinary-income tax consequences for the recipient but do not by themselves signal buying or selling intent in the market.

Insider Transaction Report

Form 4
Period: 2026-05-07
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-07+257519 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F3][F4]
    2026-05-072570 total
    Common Stock (257 underlying)
Holdings
  • Common Stock

    [F1]
    (indirect: By Trust)
    1,542
  • Common Stock

    [F2]
    (indirect: By Foundation)
    259
Footnotes (4)
  • [F1]The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust.
  • [F2]The reporting person is a trustee of The O'Hanian-Szostak Family Foundation ('Foundation') and has power to direct the distribution of assets held by the Foundation.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026.
  • [F4]Not applicable.
Signature
/s/ Lily J. Lu, Attorney-in-Fact for M. Anne Szostak|2026-05-11

Documents

1 file
  • 4
    wk-form4_1778533854.xmlPrimary

    FORM 4